Jain Rita
SEC insider (Form 3/4/5 filer). CIK 0001707797. Director at Avalo Therapeutics, Inc. (AVTX) and 4 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in WAYNE, PA.
Companies Jain Rita has filed insider reports for
- Avalo Therapeutics, Inc. (AVTX): Director
- Celldex Therapeutics, Inc. (CLDX): Director
- First Tracks Biotherapeutics, Inc. (TRAX): Director
- ANAPTYSBIO, INC (ANAB): Director
- SAB Biotherapeutics, Inc. (SABS): Director
Jain Rita
CIK: 0001707797
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Sep 30, 2026AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.3K shares at avg. $12.29- - Jun 30, 2026AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.1K shares at avg. $15.04- - Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
26K shares- - Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
ExerciseDirect7.3K shares- - Jun 2, 2026AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.1K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
42K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
15K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
16.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,322 | $12.29 | - | Direct |
| Jun 30, 2026 | AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,080 | $15.04 | - | Direct |
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 26,000 | - | - | Direct |
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise | 7,330 | - | $0 | Direct |
| Jun 2, 2026 | AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,100 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 15,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 16,510 | - | - | Direct |
1-10 of 28 transactions